The deal comes on the heels of a similar arrangement Nanostics struck with Protean BioDiagnostics for the US market.

The University of Maryland spinout said it plans to launch a point-of-care urinary tract infection test by 2025, followed by three more tests by 2028.

Less than one quarter of pathology labs have adopted whole-slide imaging so far, but pathologists and companies in the space ...

The tool uses two blood-based biomarkers and up to five clinical features to generate a risk score for prostate cancer aggressiveness.

According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million.

Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently passed spending bill.

NEW YORK – The Alzheimer's Drug Discovery Foundation on Wednesday announced that it has invested $7.0 million in Alzheimer's disease diagnostic company C2N Diagnostics. Already have a 360Dx or ...

Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.

NEW YORK – MDxHealth on Wednesday announced that it has launched a proposed offering of $40.0 million of its ordinary shares in a registered public offering. The Herstal, Belgium-based molecular ...

The partnership will include collaborative research with a focus on expanding the use of in vitro diagnostics to support antimicrobial stewardship programs.

MDxHealth also said a strategic partner is purchasing 1,500,000 ordinary shares in the offering directly from the company rather than through the underwriters.